Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis
Open Access
- 1 September 2001
- Vol. 56 (9) , 669-674
- https://doi.org/10.1136/thorax.56.9.669
Abstract
BACKGROUND Pseudomonas aeruginosa is a frequent cause of infection in patients with bronchiectasis. Differentiation between non-infected patients and those with different degrees of P aeruginosainfection could influence the management and prognosis of these patients. The diagnostic usefulness of serum IgG antibodies againstP aeruginosa outer membrane proteins was determined in patients with bronchiectasis without cystic fibrosis. METHODS Fifty six patients were classified according to sputum culture into three groups: group A (n=18) with no P aeruginosain any sample; group B (n=18) with P aeruginosa alternating with other microorganisms; and group C (n=20) with P aeruginosa in all sputum samples. Each patient had at least three sputum cultures in the 6 months prior to serum collection. Detection of antibodies was performed by Western blot and their presence against 20 protein bands (10–121 kd) was assessed. RESULTS Antibodies to more than four bands in total or to five individual bands (36, 26, 22, 20 or 18 kd) differentiated group B from group A, while antibodies to a total of more than eight bands or to 10 individual bands (104, 69, 63, 56, 50, 44, 30, 25, 22, 13 kd) differentiated group C from group B. When discordant results between the total number of bands and the frequency of P aeruginosa isolation were obtained, the follow up of patients suggested that the former, in most cases, predicted chronic P aeruginosacolonisation. CONCLUSION In patients with bronchiectasis the degree of P aeruginosa infection can be determined by the number and type of outer membrane protein bands indicating which serum antibodies are present.Keywords
This publication has 25 references indexed in Scilit:
- Lung function in bronchiectasis: the influence of Pseudomonas aeruginosaEuropean Respiratory Journal, 1996
- Immunoglobulin G antibodies toPseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Clinical management of pulmonary disease in cystic fibrosisThe Lancet, 1993
- Serum antibodies to Pseudomonas aeruginosa outer-membrane proteins and iron-regulated membrane proteins at different stages of chronic cystic fibrosis lung infectionJournal of Medical Microbiology, 1991
- Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.Thorax, 1990
- Use of immunoblot detection of serum antibodies in the diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosisJournal of Medical Microbiology, 1988
- Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.Journal of Clinical Pathology, 1986
- Quantitation and Identification of Antibodies to Outer-Membrane Proteins of Pseudomonas aeruginosa in Sera of Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1984
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970